2996
K. Yamada et al.
PAPER
washed with H2O (40 mL), 10% K2CO3 (2 × 27 mL), and brine (27
mL). The organic layer was dried (Na2SO4), filtered, and concen-
trated under reduced pressure. The residue was purified by column
chromatography (hexane–EtOAc, 19:1 to 14:1 to 9:1) to afford 2j
(137.4 mg, 90%) as a clear colorless oil.
1H NMR (CDCl3): δ = 7.27 (d, J = 8.7 Hz, 2 H), 6.88 (d, J = 8.7 Hz,
2 H), 5.89 (d, J = 3.7 Hz, 1 H), 4.61 (d, J = 11.4 Hz, 1 H), 4.57 (d,
J = 11.4 Hz, 1 H), 4.56 (d, J = 3.7 Hz, 1 H), 4.34 (ddd, J = 7.6, 8.7,
8.7 Hz, 1 H), 4.14 (dd, J = 3.0, 7.6 Hz, 1 H), 4.10 (d, J = 6.0, 8.7 Hz,
1 H), 4.00 (d, J = 3.0 Hz, 1 H), 3.99 (d, J = 6.0, 8.7 Hz, 1 H), 3.81
(s, 3 H), 1.49 (s, 3 H), 1.43 (s, 3 H), 1.38 (s, 3 H), 1.31 (s, 3 H).
LRMS (EI): 214 ([M]+).
p-Chlorophenyl p-Methoxybenzyl Ether (2m)21
To a solution of p-chlorophenol (119.3 mg, 0.928 mmol) and Tri-
BOT-PM (340.7 mg, 0.603 mmol) in THF (3.10 mL), CSA (32.3
mg, 0.139 mmol) was added at r.t. The mixture was heated to reflux
and additional TriBOT-PM was added after 1 h (90.9 mg, 0.186
mmol), 2 h (45.4 mg, 0.0927 mmol), and 5 h (22.7 mg, 0.0464
mmol), respectively. The mixture was stirred for an additional 4 h,
and it was cooled to r.t., diluted with Et2O (9 mL), and washed with
H2O (47 mL), 10% K2CO3 (3 × 9 mL), and brine (9 mL). The organ-
ic layer was dried (Na2SO4), filtered, and concentrated under re-
duced pressure. The residue was purified by column
chromatography (hexane–CHCl3, 1:1) to afford 2m (216.6 mg,
94%) as colorless crystals; mp 106.0–107.0 °C.
13C NMR (150 MHz, CDCl3): δ = 159.4, 129.7, 129.4, 113.8, 111.8,
109.0, 105.3, 82.7, 81.32, 81.31, 72.6, 72.1, 67.4, 55.3, 26.9, 26.8,
26.3, 25.5.
1H NMR (CDCl3): δ = 7.34 (d, J = 8.7 Hz, 2 H), 7.23 (d, J = 9.0 Hz,
2 H), 6.91 (d, J = 8.7 Hz, 2 H), 6.89 (d, J = 8.9 Hz, 2 H), 4.95 (s, 2
H), 3.81 (s, 3 H).
LRMS (ESI): m/z = 403 ([M + Na]+).
Methyl 2,3,4,6-Tetrakis-O-(p-methoxybenzyl)-α-D-glucopyran-
oside (2k)
13C NMR (100 MHz, CDCl3): δ = 159.5, 157.4, 129.29, 129.22,
To a solution of methyl α-D-glucopyranoside (58.3 mg, 0.300
mmol) and TriBOT-PM (235.0 mg, 0.480 mmol) in THF (4.00 mL),
CSA (41.8 mg, 0.180 mmol) was added at r.t. The mixture was heat-
ed to reflux and additional TriBOT-PM was added after 1 h (117.5
mg, 0.240 mmol), 5.5 h (33.7 mg, 0.0688 mmol), 12.5 h (58.7 mg,
0.120 mmol), 17 h (58.7 mg, 0.120 mmol), and 21 h (117.5 mg,
0.240 mmol), respectively. The mixture was stirred for an addition-
al 9 h, the mixture was cooled to r.t., diluted with Et2O (12 mL), and
washed with H2O (60 mL), 10% K2CO3 (3 × 12 mL), and brine (12
mL). The organic layer was dried (Na2SO4), filtered, and concen-
trated under reduced pressure. The residue was purified by column
chromatography (hexane–EtOAc, 4:1 to 3:1 to 2:1) followed by re-
cycling preparative HPLC to afford 2k (139.1 mg, 69%) as a clear
pale yellow oil.
128.5, 125.7, 116.1, 114.0, 70.1, 55.3.
LRMS (EI): m/z = 248 ([M]+).
Acknowledgment
This study was financially supported in part by a Grant-in-Aid for
Young Scientists (B) (23790009) from the Ministry of Education,
Culture, Sports, Science, and Technology of Japan, and by Adap-
table and Seamless Technology Transfer Program through Target-
driven R&D (Development of eco-, and user-friendly acid-catalyzed
alkylating reagents) from Japan Science and Technology Agency.
H.F. acknowledges the Grant-in-Aid for JSPS Fellows.
IR (CHCl3): 3003, 2937, 2839, 1612, 1510, 1259, 1053 cm–1.
1H NMR (CDCl3): δ = 7.28 (d, J = 8.7 Hz, 2 H), 7.28 (d, J = 8.7 Hz,
2 H), 7.24 (d, J = 8.7 Hz, 2 H), 7.01 (d, J = 8.7 Hz, 2 H), 6.86 (d, J =
8.7 Hz, 2 H), 6.85 (d, J = 8.7 Hz, 2 H), 6.84 (d, J = 8.7 Hz, 2 H),
6.80 (d, J = 8.7 Hz, 2 H), 4.88 (d, J = 10.5 Hz, 1 H), 4.74 (d, J = 10.5
Hz, 1 H), 4.73 (d, J = 11.4 Hz, 1 H), 4.72 (d, J = 10.1 Hz, 1 H), 4.58
(d, J = 11.4 Hz, 1 H), 4.56 (d, J = 11.9 Hz, 1 H), 4.54 (d, J = 3.7 Hz,
1 H), 4.39 (d, J = 11.9 Hz, 1 H), 4.33 (d, J = 10.1 Hz, 1 H), 3.91 (dd,
J = 9.2, 9.6 Hz, 1 H), 3.80 (s, 3 H), 3.80 (s, 3 H), 3.78 (s, 3 H), 3.76
(s, 3 H), 3.71–3.63 (m, 2 H), 3.60–3.52 (m, 2 H), 3.50 (dd, J = 3.7,
9.6 Hz, 1 H), 3.35 (s, 3 H).
13C NMR (150 MHz, CDCl3): δ = 159.4, 159.24, 159.18, 159.1,
131.1, 130.5, 130.3, 130.0, 129.8, 129.62, 129.60, 129.5, 113.83,
113.79, 113.74, 113.72, 98.3, 81.9, 79.5, 77.4, 75.4, 74.6, 73.05,
73.03, 70.0, 68.0, 55.28, 55.28, 55.27, 55.2, 55.1.
Supporting Information for this article is available online at
m
tgioSrantnugIifoop
r
itmnatr
References
(1) (a) Gathirwa, J. W.; Maki, T. Tetrahedron 2012, 68, 370.
(b) Encyclopedia of Reagents for Organic Synthesis; Vol. 5;
Paquette, L. A., Ed.; John Wiley: New York, 1995, 3326.
(2) (a) Greene, T. W.; Wuts, P. G. M. Greene’s Protective
Groups in Organic Synthesis; Wiley-Interscience: New
York, 2006, 4th ed. (b) Kocienski, P. J. Protecting Groups,
3rd ed.; Thieme: Stuttgart, 2003.
(3) (a) Rai, A. N.; Basu, A. Tetrahedron Lett. 2003, 44, 2267.
(b) Nakajima, N.; Horita, K.; Abe, R.; Yonemitsu, O.
Tetrahedron Lett. 1988, 29, 4139. (c) Encyclopedia of
Reagents for Organic Synthesis; Vol. 8; Paquette, L. A., Ed.;
John Wiley: NewYork, 1995, 6598.
(4) (a) Stewart, C. A.; Peng, X.; Paquette, L. A. Synthesis 2008,
433. (b) Nwoye, E. O.; Dudley, G. B. Chem. Commun. 2007,
1436. (c) Nakajima, N.; Saito, M.; Ubukata, M. Tetrahedron
2002, 58, 3561. (d) Nakano, M.; Kikuchi, W.; Matsuo, J.;
Mukaiyama, T. Chem. Lett. 2001, 424. (e) Nakajima, N.;
Saito, M.; Ubukata, M. Tetrahedron Lett. 1998, 39, 5565.
(5) (a) Chu, X.-Q.; Jiang, R.; Fang, Y.; Gu, Z.-Y.; Meng, H.;
Wang, S.-Y.; Ji, S.-J. Tetrahedron 2013, 69, 1166.
HRMS (FAB): m/z [M + H]+ calcd for C39H47O10: 675.3169; found:
675.3178.
Anal. Calcd for C39H46O10: C, 69.42; H, 6.87. Found: C, 69.63; H,
7.10.
p-Methoxybenzyl Phenyl Ether (2l)19,20
To a solution of phenol (28.2 mg, 0.300 mmol) and TriBOT-PM
(88.1 mg, 0.180 mmol) in THF (1.50 mL), BF3·OEt2 in THF (100
mM, 15.0 μL) was added at 0 °C. The mixture was stirred for 2 h,
and it was quenched by solid NaHCO3, filtered through silica gel,
and concentrated under reduced pressure. The residue was purified
by preparative TLC (hexane–CHCl3, 1:1) to afford 2l (9.6 mg, 15%)
as colorless crystals; mp 90.8–93.0 °C.
(b) Chavan, S. P.; Harale, K. R. Tetrahedron Lett. 2012, 53,
4683. (c) Bhaskar, G.; Solomon, M.; Babu, G.;
1H NMR (CDCl3): δ = 7.36 (d, J = 8.7 Hz, 2 H), 7.32–7.26 (m, 2 H),
7.00–6.93 (m, 3 H), 6.92 (d, J = 8.7 Hz, 2 H), 4.99 (s, 2 H), 3.82 (s,
3 H).
13C NMR (100 MHz, CDCl3): δ = 159.4, 158.8, 129.5, 129.2, 129.1,
120.8, 114.8, 114.0, 69.7, 55.3.
Muralidharan, D.; Perumal, P. T. Indian J. Chem., Sect. B:
Org. Chem. Incl. Med. Chem. 2010, 49, 795. (d) Yadav, J.
S.; Bhunia, D. C.; Krishna, K. V.; Srihari, P. Tetrahedron
Lett. 2007, 48, 8306. (e) Krishna, P. R.; Lavanya, B.;
Mahalingam, A. K.; Reddy, V. V. R.; Sharma, G. V. M. Lett.
Synthesis 2013, 45, 2989–2997
© Georg Thieme Verlag Stuttgart · New York